Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.40M | 13.54M | 14.67M | 12.90M | 11.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.40M | 13.54M | 14.67M | 12.90M | 11.13M |
| Cost of Revenue | 4.72M | 5.06M | 5.39M | 4.98M | 4.57M |
| Gross Profit | 7.68M | 8.48M | 9.28M | 7.92M | 6.56M |
| SG&A Expenses | 13.11M | 12.55M | 11.99M | 11.75M | 11.50M |
| Depreciation & Amortization | 2.53M | 2.61M | 2.70M | 2.67M | 2.65M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.47M | 20.32M | 20.17M | 19.48M | 18.79M |
| Operating Income | -8.07M | -6.78M | -5.50M | -6.58M | -7.66M |
| Income Before Tax | -7.18M | -6.08M | -4.98M | -6.79M | -8.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.18 | -6.08 | -4.98 | -6.79 | -8.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.18M | -6.08M | -4.98M | -6.79M | -8.59M |
| EBIT | -8.07M | -6.78M | -5.50M | -6.58M | -7.66M |
| EBITDA | -6.25M | -4.94M | -3.65M | -4.76M | -5.86M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 2.72B | 2.46B | 2.19B | 2.02B | 1.85B |
| Average Diluted Shares Outstanding | 2.72B | 2.46B | 2.19B | 2.02B | 1.85B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |